ArticleHealth affairs scholar2026
Pharmacy benefit manager policy and pharmacy stakeholder perceptions of financial pressures and closures.
Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The community pharmacy workforce provides access to medications and services, yet financial pressures and pharmacy closures threaten patient access. Pharmacy benefit managers (PBMs) influence medication reimbursement and are frequently cited as contributors to financial strain. States have enacted legislation to regulate PBM practices. This study examined state PBM laws from 2015 to 2025 and pharmacy stakeholder and workforce perceptions of factors influencing closures. Methods: Enacted state PBM legislation from 2015 to 2025 was identified using the National Academy for State Health Policy and the National Conference of State Legislatures databases and analyzed descriptively. Thirteen key informant interviews were conducted with pharmacy organization leaders and pharmacists with firsthand closure experience. Interviews focused on system-level contributors to closures and were analyzed using rapid content analysis. Results: Pharmacy benefit manager regulation expanded from 2 states in 2015 to all 50 states by 2023. Interview participants perceived PBM practices as a major contributor to financial instability and low workforce morale. While PBM policies were viewed as necessary, participants cited inconsistent enforcement and limited workforce relief. Conclusion: Despite regulations, PBM practices are perceived as key drivers of financial pressures and closures. Strengthening policy implementation and enforcement may help sustain the workforce and preserve access to care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.